Global Macrolide Antibiotics Market Overview
Antibiotics originating from Saccharopolyspora erythraea are known as macrolide antibiotics. Macrolide antibiotics have a wide range of action against many gram-positive bacteria and are bacteriostatic in nature. Soft tissue infections, respiratory infections, sexually transmitted infections, and atypical mycobacterial infections are all treated with macrolide antibiotics. Macrolide antibiotics have anti-inflammatory and immunomodulatory properties and are used to treat a variety of ailments. Macrolide antibiotics can be used as a first- or second-line therapy, depending on the situation. Erythromycin is used as a second-line treatment for allergies and is used as a first-line treatment for pertussis and other disorders. The global Macrolide antibiotics market accounted for US$ 39.7 billion in 2020 and is estimated to be US$ 118.1 billion by 2030 and is anticipated to register a CAGR of 11.5%.
Impact of Covid-19 pandemic on market
The COVID-19 virus outbreak, which began in December 2019, has spread to almost every country on the planet, prompting the World Health Organization to declare it a public health emergency. The global effects of the coronavirus disease 2019 (COVID-19) are already being felt, and the Macrolide Antibiotics market will be significantly impacted. COVID-19 has the potential to have three major effects on the global economy: directly influencing production and demand, causing supply chain and consumer instability, and having a financial impact on businesses and financial markets.
Global Macrolide Antibiotics Market Dynamics
Rising initiatives by government bodies
The growth and expansion of the antibiotics market would, in turn, boost the market for macrolide antibiotics. The demand for macrolide antibiotics will continue to increase as the incidence of bacterial skin infections rises. Government policies and regulations that favor macrolide antibiotics would produce even more lucrative growth opportunities.
Growth in business operations by emerging and small sized players
The global demand for Macrolide Antibiotics is expected to expand in the coming years, owing to the rise in antibiotic adoption. The global macrolide antibiotics market is expected to develop rapidly during the forecast period, owing to rising macrolide demand around the world. The market is also expected to rise due to the rising prevalence of bacterial skin infections and the growing number of dermatology clinics. Furthermore, the macrolide drug market is being driven by a growing elderly population, an unprecedented rate of multi-strain resistant bacterial strains, and better benefits over traditional antibiotics.
Global Macrolide Antibiotics Market Segmentation
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
Source: Prophecy Market Insights
The global Macrolide antibiotics market is segmented based on drug type, Infection, route of distribution, end-user and region.
On the basis of drug type, the global Macrolide antibiotics market is segmented into Azithromycin, erythromycin, telithromycin, calirithromycin and fidaxomycin. Based on Infection, the target market is segmented into Legionella, Mycoplasma, Peliosishepatis, bordetella pertussis and others. On the basis of route of administration, the target market is segmented into oral and parenteral. On the basis of end-user, the market is segmented into hospital, clinics, ambulatory centers and research laboratories.
Regional Insights:
On region the global Macrolide antibiotics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Because of the involvement of leading producers and cutting-edge healthcare facilities, North America is the industry leader in Macrolide Antibiotics. Their high investment in Macrolide Antibiotics R&D centers provides a complementing opportunity for the expected market value. South Asia and East Asia have supportive factors in their healthcare platforms that are expected to drive Macrolide Antibiotics market growth over the forecast period.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By drug type- Azithromycin, erythromycin, telithromycin, calirithromycin and fidaxomycin. By Infection– Legionella, Mycoplasma, Peliosishepatis, bordetella pertussis and others. By route of administration- Oral and Parenteral By End-user– hospital, clinics, ambulatory center and Research laboratories. |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For the purpose of this study, has segmented the global Macrolide antibiotics market report based on drug type, Infection, route of distribution, end-user, and region.
Global Macrolide antibiotics Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Macrolide Antibiotics Market Key Players
The key players operating in the global Macrolide antibiotics market includes AbbVie Inc., Allergan, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Eli Lilly And Company., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Novartis AG, Boehringer Ingelheim International Gmbh, Sanofi, Astrazeneca, Abbott, Bayer AG, Sandoz International GmbH and others.
Global Macrolide Antibiotics Market Company Profile
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Allergan
- AstraZeneca
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Eli Lilly And Company.
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim International Gmbh
- Others
“*” marked represents similar segmentation in other categories in the respective section
Global Macrolide Antibiotics Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Macrolide Antibiotics Strategies
- Key Questions this Study will Answer
- Market Snippet, By Drug type
- Market Snippet, By Infection
- Market Snippet, By Route of administration
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Macrolide Antibiotics Market, By Drug type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Azithromycin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Erythromycin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Telithromycin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Calirithromycin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Fidaxomycin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Macrolide Antibiotics Market, By Infection, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Legionella
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Mycoplasma pneumonia
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Peliosishepatis
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Bordetella pertussis
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Macrolide Antibiotics Market, By Route of distribution, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Oral
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Parenteral
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Macrolide Antibiotics Market, By End-User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Clinics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Ambulatory centers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Research Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Macrolide Antibiotics Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Allergan
- AstraZeneca
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Eli Lilly And Company.
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim International Gmbh
- Others
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The global Macrolide antibiotics market is segmented based on drugs type, Infection, route of administration, end-user, and region.
The global macrolide antibiotics market is expected to develop rapidly during the forecast period, owing to rising macrolide demand around the world. The market is also expected to rise due to the rising prevalence of bacterial skin infections and the growing number of dermatology clinics.
North-america dominates the market because of the involvement of leading producers and cutting-edge healthcare facilities, North America is the industry leader in Macrolide Antibiotics.
Companies are continuously raising the production and supply. Pfizer and AstraZeneca are some of the major key players in the Macrolide antibiotics market.